Drug Type Small molecule drug |
Synonyms Batabulin (USAN/INN), 巴他布林, AMG-67 (salt) + [8] |
Target |
Action inhibitors |
Mechanism β-tubulin inhibitors(Tubulin beta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2/3 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H7F6NNaO3S |
InChIKeyRRFNAEBCEOAASM-UHFFFAOYSA-N |
CAS Registry195533-98-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Unresectable Hepatocellular Carcinoma | Phase 3 | United States | 01 Mar 2003 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | China | 01 Mar 2003 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | Brazil | 01 Mar 2003 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | Poland | 01 Mar 2003 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | Puerto Rico | 01 Mar 2003 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | Russia | 01 Mar 2003 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | Singapore | 01 Mar 2003 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | South Africa | 01 Mar 2003 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | Thailand | 01 Mar 2003 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | Ukraine | 01 Mar 2003 |
Phase 2/3 | 339 | mfsisygalw(jfubjnejgf) = vnhillkqzo najvyfwrnw (zuedyfornd ) | Negative | 01 Jun 2005 | |||
mfsisygalw(jfubjnejgf) = umhpqmfmlb najvyfwrnw (zuedyfornd ) |